declined slightly from 7.2% in 1Q18 to 7.1%. Meanwhile, cost of funds for 1Q19 was maintained at 2.3% resulting in loan spread for 1Q19 at 4.8%, a slight decline from 4.9% during 1Q18. 6 % 1Q18 2Q18 3Q18
/ Other Risks (โปรดระบ)ุ 4/ ผล Stress Test ของทั้งกอง 5/ 1/ เช่น การเปลี่ยนแปลงของราคา หรือดัชนีราคาหุ้น, yield curve, ราคาสินค้าโภคภัณฑ์ อัตราแลกเปลี่ยน หรืออ่ืน ๆ 2/ เช่น การเปลี่ยนแปลงของ credit spread
THB 2.6B. • Strong performance for Combined PET, given COVID disruption, driven by strong PET demand, higher Integrated PET spread, lower costs, improved PIA margin. • Integrated Oxides & Derivatives
1.4% for 1Q21 comparing to 1.9% for 1Q20 from continuous cost management in line with the decline in policy rate and market deposit rates during the past periods. Overall, resulting in loan spread for
with low traveling demand and cooperated with government orders as well as the announcement from Civil Aviation Authority of Thailand (CAAT) regarding to COVID-19 spread out situation. As a result, for
No. ECF2 035/2562 23 September 2562 Subject Notification on the resolutions of the Board of Directors’ Meeting approving the purchase of the ordinary shares in KPN Academy Company Limited, the increase of registered capital, the issuance and the allocation of the newly-issued shares to specific persons (Private Placement) and the convening of the Extraordinary General Meeting of Shareholders No. 1/2019 (additional) To Director and Manager The Stock Exchange of Thailand Enclosure 1. Information M...
No. ECF2 035/2562 23 September 2562 Subject Notification on the resolutions of the Board of Directors’ Meeting approving the purchase of the ordinary shares in KPN Academy Company Limited, the increase of registered capital, the issuance and the allocation of the newly-issued shares to specific persons (Private Placement) and the convening of the Extraordinary General Meeting of Shareholders No. 1/2019 (2nd additional) To Director and Manager The Stock Exchange of Thailand Enclosure 1. Informati...
, and review of development cost in accordance with project budget. After consideration of the above, benefits to be gained from alterations of conditions do not match development input, thus project
facial cleansing products gained most popularity from customers in the Philippines. Table 1: Sales Revenue by Product Line for the Three Months Period Ended 30 September Product Line/ Business Group
services grew by 78.56mb and other income gained 3.12mb. Sales and Services revenue For the 1H 2020, The Humanica Group of Companies (“HUMAN” or the “Company”) delivered sales and service revenue of 346.35mb